After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
In phase 2, VK2735 reduced patients' weight by about 15% after 13 weeks of treatment and maintained a clean safety profile.
MedPage Today on MSN15hOpinion
'Physician Spending Is Not the Problem in Healthcare': What We Heard This Week"It's very, very clear that physician spending is not the problem in healthcare." -- Jen Brull, MD, president of the American ...
Barchart on MSN6h
Here's What to Expect From DexCom's Next Earnings ReportWith a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous ...
The Healthy on MSN20h
6 Foods To Eat on Semaglutides, Listed by a Doctor of Obesity MedicineNearly two-thirds (64%) of Americans who have tried weight loss injections report the drugs as being “extremely effective” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback